Employee Benefits
Brown & Brown Releases 2026 Employer Health and Benefits Strategy Survey: Cost Control Takes Center Stage
Brown & Brown Releases 2026 Employer Health and Benefits Strategy Survey: Cost Control Takes Center Stage
(Dallas, TX – December 8, 2025) — Brown & Brown today announced the findings of its second annual Employer Health and Benefits Strategy Survey, 2026, capturing insights from 1,241 employers across the United States. The 2026 edition* reveals a benefits landscape shaped by rising costs, evolving workforce needs and a growing emphasis on innovation and sustainability.
With escalating medical and pharmacy costs, employers have moved cost-containment, for both their organizations and their employees, to the top of their strategic priorities list (See Figure 1). In the inaugural 2025 edition of the survey, employers ranked ‘attracting and retaining a competitive workforce’ as their top priority. Some of the popular strategic cost containment initiatives include evaluating stop-loss plan design, conducting audits and partnering with digital health solutions to enhance plan transparency and effectiveness.
Despite the focus on cost control, employers remain committed to supporting employee well-being. A majority (77%) say well-being programs are part of their healthcare strategies, and 78% of this cohort plan to increase related budgets. Parental leave enhancements are also on the rise, with 71% of employers offering paid leave beyond statutory requirements.
“Employers are taking decisive action to manage rising health care costs, from rethinking plan design to adopting digital care solutions and more rigorous pharmacy management strategies,” said Chana Bieker, senior vice president – benefits, national account leader at Brown & Brown. “Amid inflation, economic volatility and shifting social expectations, our survey shows organizations are prioritizing cost control more than ever. At the same, they are utilizing available budget to reinvest in employee well-being in diverse ways, such as more inclusive benefits and expanded parental leave.”
Amidst the ever-growing popularity of GLP-1 drugs for weight loss, the survey also highlights the continued struggle for employers trying to balance access and cost (See Figure 2). Nearly half of respondents cover GLP-1s for weight loss (48%), with the vast majority of this respondent group planning to continue coverage over the next one to two years (89%). However, for those that do cover GLP-1s for weight loss, more than six in ten have restrictions in place (63%). A significant percentage of these employers have restrictions beyond prior authorization, such as having to meet certain clinical criteria above and beyond FDA guidelines (49%).
*About the Survey
The second annual Brown & Brown Employer Health and Benefits Strategy Survey, 2026, gathered responses from 1,241 employers. Participating employers had at least 200 employees based in the US. The survey explores a wide array of key strategic issues and opportunities facing employers who sponsored employee health and benefits plans. The survey was fielded from July 31 through September 5, 2025. The margin of error is +/-3%. Download the Executive Summary here https://www.bbrown.com/us/insight/employer-health-and-benefits-strategy-survey-2026/
Upcoming Webinar
Members of the media are invited to join a webinar about the survey results on Wednesday, December 10, 2025, 1:00 – 2:00 pm ET. All registrants will receive a replay link and copy of the presentation. Register here: https://www.bbrown.com/us/employer-health-and-benefits-strategy-survey-2026/
About Brown & Brown
Brown & Brown, Inc. (NYSE: BRO) is a leading insurance brokerage firm delivering comprehensive and customized insurance solutions and specialization since 1939. With a global presence spanning 700+ locations and a team of more than 23,000 professionals, we are dedicated to delivering scalable, innovative strategies for our customers at every step of their growth journey. Learn more at BBrown.com.
Figure 1: Top Strategic Priorities
Amid escalating medical and pharmacy cost trends, employers are increasingly prioritizing cost containment strategies.

Figure 2: GLP-1s for Weight Loss
Strategies for coverage of GLP-1s for weight loss continue to evolve.

